G01N 2333/91215
With a definite ec number
Official title: with a definite EC number (2.7.1.-)
G01N2333/91215 (With a definite ec number) appears on 180 US grants and 363 published applications in this corpus.
Search patents in G01N- Granted patents
- 180
- Published applications
- 363
- Assignees
- 273
- Inventors
- 859
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 7 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 0 | 4 |
| 2003 | 1 | 9 |
| 2004 | 1 | 8 |
| 2005 | 5 | 9 |
| 2006 | 3 | 19 |
| 2007 | 3 | 11 |
| 2008 | 6 | 19 |
| 2009 | 2 | 21 |
| 2010 | 9 | 22 |
| 2011 | 9 | 17 |
| 2012 | 9 | 14 |
| 2013 | 9 | 12 |
| 2014 | 5 | 21 |
| 2015 | 9 | 21 |
| 2016 | 13 | 24 |
| 2017 | 9 | 16 |
| 2018 | 13 | 15 |
| 2019 | 9 | 18 |
| 2020 | 12 | 14 |
| 2021 | 11 | 14 |
| 2022 | 10 | 12 |
| 2023 | 3 | 7 |
| 2024 | 7 | 13 |
| 2025 | 3 | 15 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for treating cancer31 Mar 2026US 12,590,966 B2Children's Medical Center Corporation
- Hexokinase 1 isoform B for use as a prognosis marker and specific target against cancer17 Mar 2026US 12,578,339 B2
- Determination of canine TK1 protein levels17 Mar 2026US 12,578,340 B2Alertix Veterinary Diagnostics AB
- Ratio between PLGF and sFLt1 is predictive for neural invasion in patients suffering from pancreatic cancer24 Feb 2026US 12,560,611 B2Charite-Universitaetsmedizin Berlin
- Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biological molecules17 Feb 2026US 12,553,881 B2Wisconsin Alumni Research Foundation
- Methods of Assessing Dementia Risk27 Aug 2026US 2026/0251664 A1SomaLogic Operating Co., Inc.
- Dry paper-based test strip potassium assay13 Aug 2026US 2026/0235499 A1Jana Care, Inc.
- Ovarian cancer risk prediction13 Aug 2026US 2026/0235608 A1Arocell AB
- Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biological molecules6 Aug 2026US 2026/0227381 A1Wisconsin Alumni Research Foundation
- Apparatus and methods using coupled enzyme luminescence assays for the detection of analytes and biomarkers2 Jul 2026US 2026/0185138 A1TETmedical, Inc.
Most cited
By later US patents
- Methods of modulating serine/thereonine protein kinase function with quinazoline-based compounds36US 6,204,267 B1Sugen, Inc. · 2001
- Multiplexed enzymatic assays27US 6,846,645 B2Aclara Biosciences, Inc. · 2005
- Azaindole derivatives as inhibitors of protein kinases23US 9,493,455 B2Oribase Pharma · 2016
- Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds22US 6,911,446 B2Sugen, Inc. · 2005
- Multiplexed enzymatic assays18US 6,630,296 B2Aclara Biosciences, Inc. · 2003